Roche (OTCQX:RHHBY) said Monday that three obesity and diabetes drug candidates acquired through its takeover of Carmot ...

Roche has agreed a deal to acquire US biotech Carmot Therapeutics that, if consummated, will thrust it into the increasingly competitive market for incretin-based therapies for diabetes and obesity.

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics as it tries to catch up with the leaders in the fast ...

The January report came after Viking (VKTX) shares had already skyrocketed 86% amid takeover speculation after Roche ...

Roche forayed into the obesity market after it acquired privately owned Carmot Therapeutics for $2.7 billion last year. The acquisition gave Roche access to Carmot’s differentiated portfolio of ...

RecycLiCo Battery Materials Engages Carmot Strategic Group and Penney Capital for Grants and Cooperative Funding Consultation RecycLiCo Battery Materials Tue, Jan 28, 2025, 6:00 AM 4 min read ...

The companies will assist efforts to identify and qualify for government funding opportunities for critical mineral recovery activities in the U.S. and Canada. SURREY — RecycLiCo Battery ...

Carmot Strategic and Penney Capital advisory companies have won multiple federal grants to develop domestic sources of Critical Minerals, from mining and processing to advanced materials ...